Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-03-000796
Filing Date
2003-01-17
Accepted
2003-01-17 15:45:49
Documents
1
Period of Report
2003-01-15

Document Format Files

Seq Description Document Type Size
1 WP VIII FORM 4 rrd3664.htm 4 19316
  Complete submission text file 0001181431-03-000796.txt   21298
Mailing Address 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21589 | Film No.: 03517892
SIC: 2834 Pharmaceutical Preparations

Mailing Address 466 LEXINGTON AVENUE NEW YORK NY 10017
Business Address 466 LEXINGTON AVENUE NEW YORK NY 10017 2128780600
WARBURG PINCUS PRIVATE EQUITY VIII L P (Reporting) CIK: 0001157334 (see all company filings)

EIN.: 134161869 | State of Incorp.: DE | Fiscal Year End: 1231